We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments... Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. Show more
PITTSBURGH, May 02, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting...
PITTSBURGH, April 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its first...
• Received Fast Track Designations for both inhaled and intratumoral KB707 PITTSBURGH, April 22, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a...
PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting...
PITTSBURGH, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.82 | 3.0842078321 | 156.28 | 164.74 | 152.16 | 244852 | 157.9428124 | CS |
4 | -17.07 | -9.5807374979 | 178.17 | 182.51 | 152.16 | 251592 | 166.00054423 | CS |
12 | 49.55 | 44.4195428059 | 111.55 | 189.97 | 107.5 | 392235 | 160.14570444 | CS |
26 | 41.74 | 34.9698391421 | 119.36 | 189.97 | 93.95 | 357742 | 137.09948858 | CS |
52 | 77.63 | 93.0034743021 | 83.47 | 189.97 | 82.09 | 325499 | 127.92471271 | CS |
156 | 80.09 | 98.8643377361 | 81.01 | 189.97 | 38.8563 | 243674 | 95.46060126 | CS |
260 | 129.36 | 407.561436673 | 31.74 | 189.97 | 22.02 | 209777 | 81.5880745 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions